Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

被引：0
|
作者：
Kwan, C.
Frouni, I.
Bedard, D.
Nuara, S.
Gourdon, J.
Huot, P.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1333
引用
收藏
页码：S587 / S587
页数：1
相关论文
共 50 条
  • [1] The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset
    Kwan, Cynthia
    Frouni, Imane
    Bedard, Dominique
    Hamadjida, Adjia
    Nuara, Stephen G.
    Gourdon, Jim C.
    Huot, Philippe
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (06) : 1169 - 1176
  • [2] Evaluation of the effect of adding a mGlu2/3 orthosteric antagonist to a highly selective 5-HT2A antagonist on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset
    Nuara, S.
    Gourdon, J.
    Huot, P.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S314 - S314
  • [3] 5-HT2A receptor levels are increased in dyskinetic. MPTP-lesioned macaques
    Huot, P.
    Johnston, T. H.
    Winkelmolen, L.
    Fox, S. H.
    Brotchie, J. M.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S414 - S414
  • [4] 5-HT2A blockade for dyskinesia and psychosis in Parkinson’s disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review
    Cynthia Kwan
    Imane Frouni
    Dominique Bédard
    Stephen G. Nuara
    Jim C. Gourdon
    Adjia Hamadjida
    Philippe Huot
    [J]. Experimental Brain Research, 2019, 237 : 435 - 442
  • [5] 5-HT2A blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review
    Kwan, Cynthia
    Frouni, Imane
    Bedard, Dominique
    Nuara, Stephen G.
    Gourdon, Jim C.
    Hamadjida, Adjia
    Huot, Philippe
    [J]. EXPERIMENTAL BRAIN RESEARCH, 2019, 237 (02) : 435 - 442
  • [6] Effect of a 5-HT2A/2C receptor agonist on spinal glial activation
    Surchev, K.
    Surcheva, S.
    Surchev, L.
    Vlaskovska, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S249 - S250
  • [7] 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
    Huot, Philippe
    Johnston, Tom H.
    Winkelmolen, Lieke
    Fox, Susan H.
    Brotchie, Jonathan M.
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (01) : 194.e5 - 194.e15
  • [8] Effect of the mGlu2/3 orthosteric agonist LY-404,039 on dyskinesia, psychosis-like behaviours, and parkinsonism in the MPTP-lesioned marmoset
    Kang, W.
    Nuara, S.
    Gourdon, J.
    Huot, P.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S313 - S313
  • [9] Effect of the 5-HT2A/2c receptor agonist DOI on female rat sexual behavior
    Rössler, AS
    Bernabé, J
    Denys, P
    Alexandre, L
    Giuliano, F
    [J]. JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03): : 432 - 441
  • [10] Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice
    Buzzi, Belle
    Alsharari, Shakir D.
    Walentiny, David M.
    Damaj, M. Imad
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2024, 467
12345